Common questions about Simpesse (FAQ)
Q: Can Simpesse be used for any purpose other than preventing pregnancy?
A: According to official information, Simpesse is a combination oral contraceptive indicated solely for the purpose of preventing pregnancy in women of reproductive potential. No other indications are listed in the official product labeling.
Q: What is the difference between Simpesse and a 'monthly' birth control pill regimen?
A: Simpesse is an extended-cycle regimen that involves taking active tablets for 84 consecutive days, followed by 7 days of low-dose estrogen tablets. This schedule is designed to result in a withdrawal bleed, similar to a menstrual period, approximately once every three months, unlike traditional monthly pills.
Q: How does Simpesse work to prevent pregnancy according to official information?
A: The primary mechanism of Simpesse is to prevent pregnancy by suppressing ovulation (the release of an egg). Secondary actions described in regulatory documents include changing the consistency of the cervical mucus and modifying the endometrium (uterine lining) to establish auxiliary physiological modifications.
Q: Does Simpesse help with regulating menstrual periods or managing blood loss?
A: Simpesse is not indicated for the purpose of regulating menstrual periods or managing blood loss. Official safety information lists irregular and/or heavy uterine bleeding as a very common side effect reported in clinical trials.
Q: Is it normal to experience spotting or breakthrough bleeding while taking Simpesse?
A: Bleeding irregularities, which can include spotting or breakthrough bleeding, are listed as a very common side effect of Simpesse. Bleeding irregularities are common and often observed, especially during the initial cycles of use as the body adjusts to the extended-cycle regimen.
Q: What backup methods of contraception are officially recommended when first starting Simpesse?
A: Regulatory documents recommend using a non-hormonal back-up method of contraception when first starting Simpesse. Non-hormonal methods, such as condoms or spermicide, are advised for use until the active tablets have been taken daily for seven consecutive days.
Q: Does Simpesse protect against sexually transmitted infections (STIs)?
A: Official safety warnings state that Simpesse does not protect against HIV infection (the virus that causes AIDS) and other sexually transmitted infections (STIs). Non-hormonal barrier methods are generally recommended for protection against STIs.
Q: Is weight change a reported possible side effect of Simpesse use?
A: Weight gain is listed in official documents as a common adverse reaction, affecting 1% to 10% of users in clinical trials. Weight loss is not listed among the common or very common side effects in the official product information.
Q: Are there any reports of mood changes or anxiety related to Simpesse?
A: Official labeling advises that women with a history of depression should be carefully observed while taking Simpesse. The medication may be discontinued if depression returns to a serious degree, and evaluation by a healthcare provider is generally recommended. Data on the association of this class of drug with the onset or worsening of depression are limited.
Q: Is there a reported risk of migraine headaches associated with taking Simpesse?
A: Headache is listed as a very common adverse reaction in official product information. If significant or concerning changes in headaches occur while taking Simpesse, evaluation by a healthcare provider is generally recommended, and discontinuation may be considered.
Q: Is nausea or stomach pain a common effect when first starting Simpesse?
A: Nausea and vomiting are listed as very common side effects, and abdominal pain is a common side effect. While these are frequently reported overall, the official labeling does not specifically distinguish whether these symptoms occur only when a person first starts the medication.
Q: Does Simpesse have any effect on the risk of certain cancers?
A: Simpesse is contraindicated (must not be used) in women with breast cancer. Epidemiology studies have shown no consistent link between combination oral contraceptives (COCs) and breast cancer risk, but some evidence suggests a small increase in risk for current or recent COC users. Some studies also suggest a possible increase in the risk of cervical cancer.
Q: Does Simpesse carry a warning for women who have a history of jaundice during pregnancy?
A: The official warning indicates that Simpesse is generally discontinued if jaundice (yellowing of the skin or eyes) develops during use. Additionally, women with a history of chloasma (darkening of skin, often during pregnancy) should note that official guidance suggests avoiding sun or UV radiation while taking the medication.
Q: Can Simpesse affect blood sugar levels in women with pre-existing conditions like diabetes?
A: Combined hormonal contraceptives like Simpesse may cause adverse carbohydrate and lipid metabolic effects (changes to fat/cholesterol and sugar levels). Official information states that monitoring of glucose levels is generally advised for women with prediabetic or diabetic conditions.
Q: What reports exist about acne being affected by Simpesse?
A: Acne is listed in official documentation as a common adverse reaction, reported in 1% to 10% of users in clinical trials. The regulatory documents list acne as a possible effect but do not specify whether it typically causes improvement or worsening.
Q: Are there any general warnings about taking Simpesse with antibiotics?
A: Regulatory warnings exist regarding specific antibiotics that can interact with Simpesse and potentially reduce its contraceptive effectiveness. These interacting drugs include rifampin, rifabutin, rifapentine, griseofulvin, penicillins, and tetracyclines.
Q: What classes of anticonvulsant or antiepileptic drugs may interact with Simpesse?
A: Certain classes of anticonvulsant or antiepileptic drugs, such as carbamazepine and phenobarbital, are known to interact with Simpesse. This interaction occurs by potentially reducing the level of contraceptive hormones in the body, which can decrease the pill's effectiveness.
Q: Does grapefruit juice interact with Simpesse or similar hormonal contraceptives?
A: According to official interaction information, grapefruit juice may cause the blood levels of levonorgestrel (one of the active ingredients) to increase. For this reason, official guidance suggests limiting consumption of grapefruit juice while using Simpesse.
Q: Can Simpesse be used in teenage females who have not started menstruation?
A: Simpesse is officially indicated for use by females of reproductive potential, which is defined as women who have already begun menstruation (post-menarche). Use in females who have not yet started their period is not covered by the official indications.
Q: Does Simpesse contain the same hormones as Plan B or other emergency contraceptives?
A: Simpesse contains a combination of two active hormones, Levonorgestrel and Ethinyl Estradiol. Emergency contraception pills, such as Plan B, typically contain only a higher dose of the progestin hormone, Levonorgestrel.
Q: Are there any official reports on the effect of Simpesse on cholesterol or lipid levels?
A: Combined hormonal contraceptives may cause adverse lipid metabolic effects (changes to fat/cholesterol levels). Monitoring of lipid levels may be advised for women with existing conditions like uncontrolled dyslipidemias while using the medication.
Q: What is the reported failure rate of Simpesse when taken correctly?
A: Official clinical studies cite the perfect use failure rate for this type of hormonal regimen. The reported perfect use failure rate in clinical studies for this type of hormonal regimen is generally cited in the range of 0.3% to 1% annually.
